Treatment with synergistic combination of (CS and ART using 0/0 h) over-restored Op18 expression, suggesting the selected treatment may have disturbed its morphogenetic signalling preventing cell proliferation that in turn led to growth inhibition, indicating that treatment could be an effective means to sensitize cancer calls towards cisplatin. Here, STMN1 is linked to cancer.